evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract
5131,GENE_BACKGROUND,,"The FLT3 gene encodes a type 3 transmembrane receptor tyrosine kinase (PMID: 12032772). The receptor is activated following dimerization and autophosphorylation upon binding by its ligand, FLT3L. FLT3 activation results in increased signaling through several pathways including the MAP-kinase, PI3-kinase/AKT and STAT3/5 pathways, which have roles in hematopoietic proliferation, differentiation and survival (PMID: 23631653, 12951584). Wildtype FLT3 is important for the growth and differentiation of hematopoietic stem cells, however, loss of FLT3 in murine models is not sufficient to cause leukemogenesis (PMID: 23631653). Therefore, additional oncogenic alterations cooperate with over-activation of FLT3 to cause malignancy. FLT3 is commonly expressed on immature myeloid and lymphoid cells, and therefore FLT3 alterations most typically give rise to leukemias (PMID: 12951584). The most common leukemic FLT3 alterations include FLT3 internal tandem duplications (FLT3-ITD) (about 25% of adult acute myeloid leukemias (AMLs)) and point mutations in the tyrosine kinase domain (about 7% of adult AMLs) (PMID: 24319184). FLT3 small molecule kinase inhibitors have been developed and are currently being tested in clinical trials (PMID: 24682858).",,2017-04-08,,2322,FLT3,fms related tyrosine kinase 3,True,ENST00000241453,NM_004119.2,STK1,FLK-2,CD135,FLK2,False,23631653,FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations.,Leukemia &amp; lymphoma,2018-02-01T20:14:00,55,2,243-55,Kayser S et al,doi: 10.3109/10428194.2013.800198,,0001-02-01,,24682858,FLT3 inhibitors in AML: are we there yet?,Current hematologic malignancy reports,2018-06-01T20:14:00,9,2,174-85,Sudhindra A et al,doi: 10.1007/s11899-014-0203-8,,0001-06-01,,12951584,The role of FLT3 in haematopoietic malignancies.,Nature reviews. Cancer,2018-09-01T20:03:00,3,9,650-65,Stirewalt DL et al,,,0001-09-01,,12032772,Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease.,Oncogene,2018-05-13T20:02:00,21,21,3314-33,Scheijen B et al,,,0001-05-13,,24319184,FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?,Hematology. American Society of Hematology. Education Program,2013,2013,,220-6,Levis M,doi: 10.1182/asheducation-2013.1.220,,Levis M. Hematology. American Society of Hematology. Education Program. 2013;2013()220-6.,
5130,GENE_SUMMARY,,"FLT3, a receptor tyrosine kinase, is recurrently altered in acute myeloid leukemia and other hematologic malignancies.",,2017-04-08,,2322,FLT3,fms related tyrosine kinase 3,True,ENST00000241453,NM_004119.2,STK1,FLK-2,CD135,FLK2,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
